CSPG4 acts as an oncogenic driver in melanoma, promoting growth and survival of malignant cells by signaling through various pathways [23], and therefore cannot be easily down‐regulated by the tumor to escape CSPG4‐targeted therapies. This evidence concerns the gene CSPG4 and neoplasm.